相似文献
1
Autoimmune autonomic ganglionopathy: treatment by plasma exchanges and rituximab.
Clin Auton Res. 2009 Aug;19(4):259-62. doi: 10.1007/s10286-009-0012-7. Epub 2009 Apr 28.
2
Long-term treatment with rituximab of autoimmune autonomic ganglionopathy in a patient with lymphoma.
Arch Neurol. 2011 Mar;68(3):372-5. doi: 10.1001/archneurol.2010.289. Epub 2010 Nov 8.
3
Immunotherapy for autoimmune autonomic ganglionopathy.
Auton Neurosci. 2009 Mar 12;146(1-2):22-5. doi: 10.1016/j.autneu.2008.11.001. Epub 2008 Dec 4.
4
Autoimmune autonomic ganglionopathy: an update on diagnosis and treatment.
Expert Rev Neurother. 2018 Dec;18(12):953-965. doi: 10.1080/14737175.2018.1540304. Epub 2018 Nov 1.
5
Clinical laboratory evaluation of autoimmune autonomic ganglionopathy: Preliminary observations.
Auton Neurosci. 2009 Mar 12;146(1-2):18-21. doi: 10.1016/j.autneu.2008.12.004. Epub 2009 Jan 19.
6
Clinical Problem Solving: A Tobacco Merchant Who Can't Spit.
Isr Med Assoc J. 2017 Dec;19(12):786-791.
7
Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy.
Auton Neurosci. 2009 Mar 12;146(1-2):3-7. doi: 10.1016/j.autneu.2008.09.005. Epub 2008 Oct 31.
8
Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy.
Clin Auton Res. 2015 Aug;25(4):255-8. doi: 10.1007/s10286-015-0299-5. Epub 2015 Aug 7.
9
Case of autoimmune autonomic ganglionopathy manifesting anhidrosis.
J Dermatol. 2017 Oct;44(10):1160-1163. doi: 10.1111/1346-8138.13870. Epub 2017 Jun 16.
10
Autoimmune autonomic ganglionopathy with Sjögren's syndrome: significance of ganglionic acetylcholine receptor antibody and therapeutic approach.
Auton Neurosci. 2009 Mar 12;146(1-2):33-5. doi: 10.1016/j.autneu.2008.12.002. Epub 2008 Dec 21.
引用本文的文献
1
Need for combined therapy for a rare case of autoimmune autonomic ganglionopathy: A case report.
World J Methodol. 2025 Dec 20;15(4):101459. doi: 10.5662/wjm.v15.i4.101459.
2
A case of relapsed gAChR-positive autoimmune autonomic ganglionopathy treated by plasma exchange and mycophenolate mofetil.
Front Neurol. 2025 Jan 10;15:1533840. doi: 10.3389/fneur.2024.1533840. eCollection 2024.
3
Effectiveness of treatment for 31 patients with seropositive autoimmune autonomic ganglionopathy in Japan.
Ther Adv Neurol Disord. 2022 Aug 3;15:17562864221110048. doi: 10.1177/17562864221110048. eCollection 2022.
4
Autoimmune autonomic neuropathies and ganglionopathies: epidemiology, pathophysiology, and therapeutic advances.
Clin Auton Res. 2019 Jun;29(3):277-288. doi: 10.1007/s10286-019-00611-1. Epub 2019 May 15.
5
Ganglionic Antibody Level as a Predictor of Severity of Autonomic Failure.
Mayo Clin Proc. 2018 Oct;93(10):1440-1447. doi: 10.1016/j.mayocp.2018.05.033. Epub 2018 Aug 28.
6
Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.
Neurotherapeutics. 2016 Jan;13(1):163-78. doi: 10.1007/s13311-015-0393-3.
7
Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy.
Clin Auton Res. 2015 Aug;25(4):255-8. doi: 10.1007/s10286-015-0299-5. Epub 2015 Aug 7.
8
Clinical features of autoimmune autonomic ganglionopathy and the detection of subunit-specific autoantibodies to the ganglionic acetylcholine receptor in Japanese patients.
PLoS One. 2015 Mar 19;10(3):e0118312. doi: 10.1371/journal.pone.0118312. eCollection 2015.
9
Predominant Glandular Cholinergic Dysautonomia in Patients With Primary Sjögren's Syndrome.
Arthritis Rheumatol. 2015 May;67(5):1345-52. doi: 10.1002/art.39044.
10
The clinical approach to autonomic failure in neurological disorders.
Nat Rev Neurol. 2014 Jul;10(7):396-407. doi: 10.1038/nrneurol.2014.88. Epub 2014 May 27.
本文引用的文献
1
B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.
J Neuroimmunol. 2008 Nov 15;204(1-2):1-12. doi: 10.1016/j.jneuroim.2008.07.019.
2
Characterization of ganglionic acetylcholine receptor autoantibodies.
J Neuroimmunol. 2008 Jun 15;197(1):63-9. doi: 10.1016/j.jneuroim.2008.03.017. Epub 2008 May 15.
3
Plasma exchange for primary autoimmune autonomic failure.
N Engl J Med. 2005 Oct 13;353(15):1585-90. doi: 10.1056/NEJMoa051719.
4
Pandysautonomia associated with impaired ganglionic neurotransmission and circulating antibody to the neuronal nicotinic receptor.
Clin Auton Res. 2002 Aug;12(4):281-5. doi: 10.1007/s10286-002-0020-3.
5
Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies.
N Engl J Med. 2000 Sep 21;343(12):847-55. doi: 10.1056/NEJM200009213431204.
Zotero 插件